Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 11901-11910 of 13618

Page
per page
  1. Escitalopram Oxalate
    B2238 Escitalopram Oxalate
    Summary: Selective 5-HT reuptake inhibitor
      ≥10.6 mg/mL
  2. Alvelestat
    B1037 Alvelestat
    Target: NE
    Summary: NE inhibitor
      ≥27.3 mg/mL
  3. GNE-617 hydrochloride
    B1309 GNE-617 hydrochloride
    Target: Nampt
    Summary: NAMPT inhibitor, potent and competitive
      Soluble in DMSO
  4. BIX 02565
    B1295 BIX 02565
    Target: S6 kinases
    Summary: RSK2 inhibitor
      ≥22.95 mg/mL
  5. MDL-29951
    B1038 MDL-29951
    Summary: Glycine antagonist of NMDA receptor activation
      Soluble in DMSO
  6. Esomeprazole Sodium
    B1388 Esomeprazole Sodium
    Summary: Proton pump inhibitor
      ≥140.8 mg/mL
  7. Temozolomide
    B1399 Temozolomide
     4 Citation
    Summary: small-molecule alkylating agent and DNA damage inducer
      insoluble in EtOH; insoluble in H2O; ≥29.61 mg/mL
  8. GW441756
    B2297 GW441756
     1 Citation
    Target: Trk Receptors
    Summary: TrkA inhibitor,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥13.75 mg/mL
  9. Valganciclovir HCl
    B1864 Valganciclovir HCl
    Summary: prodrug for ganciclovir
      insoluble in EtOH; ≥11.4 mg/mL
  10. Doxifluridine
    B2092 Doxifluridine
    Summary: oral prodrug of the antineoplastic agent 5-fluorouracil (5-FU)
      insoluble in EtOH; ≥10 mg/mL

Items 11901-11910 of 13618

Page
per page